Patent ID: 6960651

Claim:
An isolated polypeptide selected from the group consisting of: a) a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO: 61, SEQ ID NO: 63, or the amino acid sequence encoded by the cDNA clone deposited with ATCC® as Accession number PTA-151, wherein the fragment comprises at least 200 contiguous amino acid residues of SEQ ID NO: 61, SEQ ID NO: 63, or the amino acid sequence encoded by the cDNA clone; b) a polypeptide comprising an amino acid sequence which has at least 95% sequence identity to SEQ ID NO: 61, SEQ ID NO: 63, or the amino acid sequence encoded by the cDNA clone deposited with ATCC® as Accession number PTA-151; and c) a polypeptide which is encoded by a nucleic acid molecule comprising a nucleotide sequence which has at least 95% sequence identity to SEQ ID NO: 59, SEQ ID NO: 60, or the nucleotide sequence of the cDNA clone deposited with ATCC® as Accession number PTA-151; wherein the polypeptide or fragment thereof has the ability to: i) bind to hyaluronic acid; ii) bind to extracellular matrix; iii) bind to neural cells; or iv) bind to brain cells.